1. BCL2 and miR-181a transcriptional alterations in umbilical-cord blood cells can be putative biomarkers for obesity
   João Paulo de Castro Marcondes et al, 2018, Mutation Research/Genetic Toxicology and Environmental Mutagenesis CrossRef
2. EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma
   Shanqiang Qu et al, 2021, Frontiers in Immunology CrossRef
3. Angiogenic Gene PTK2 is a Potential Biomarker of Gestational Diabetes Mellitus and is Significantly Associated with Breast Cancer Immune Infiltration
   Xuelian Du et al, 2022, Oncologie CrossRef
4. Plasma cytokines during pregnancy provide insight into the risk of diabetes in the gestational diabetes risk group
   Aili Tagoma et al, 2022, Journal of Diabetes Investigation CrossRef
5. Visceral Adipose Tissue Inflammatory Factors (TNF-Alpha, SOCS3) in Gestational Diabetes (GDM): Epigenetics as a Clue in GDM Pathophysiology
   Rebecca C. Rancourt et al, 2020, International Journal of Molecular Sciences CrossRef
6. Genomics and Epigenomics of Gestational Diabetes Mellitus: Understanding the Molecular Pathways of the Disease Pathogenesis
   Nadia Abu Samra et al, 2022, International Journal of Molecular Sciences CrossRef
7. Key genes and co‐expression network analysis in the livers of type 2 diabetes patients
   Lu Li et al, 2019, Journal of Diabetes Investigation CrossRef
8. DNA methylation analysis reveals the effect of arsenic on gestational diabetes mellitus
   Ying Gao et al, 2023, Genomics CrossRef
9. Molecular pathophysiology of diabetes mellitus during pregnancy with antenatal complications
   Arthur T. Kopylov et al, 2020, Scientific Reports CrossRef